Human CD38 ligand. A 120-KDA protein predominantly expressed on endothelial cells
1996 · The Journal of Immunology · 113 citations
https://doi.org/10.4049/jimmunol.156.2.727
A
Alberto L. Horenstein
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
5.2K
Citations
35
h-index
59
i10-index
Alberto L. Horenstein is an academic researcher from University of Turin. The author has contributed to research in topics: Calcium signaling and nucleotide metabolism & Adenosine and Purinergic Signaling & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 35, co-authored 84 publications.
ORCID: 0000-0002-0382-0595Papers by this author
worksAnti-CD38 Antibody Therapy: Windows of Opportunity Yielded by the Functional Characteristics of the Target Molecule
2013 · Molecular Medicine · 63 citations
https://doi.org/10.2119/molmed.2013.00009
The CD157-Integrin Partnership Controls Transendothelial Migration and Adhesion of Human Monocytes
2011 · Journal of Biological Chemistry · 59 citations
https://doi.org/10.1074/jbc.m111.227876
CD38 and CD157 Ectoenzymes Mark Cell Subsets in the Human Corneal Limbus
2009 · Molecular Medicine · 48 citations
https://doi.org/10.2119/molmed.2008.00108
CD38 and CD157 as Receptors of the Immune System: A Bridge Between Innate and Adaptive Immunity
2006 · Molecular Medicine · 47 citations
https://doi.org/10.2119/2006-00094.malavasi
Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects
2025 · Frontiers in Immunology · 9 citations
https://doi.org/10.3389/fimmu.2025.1519300
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat